7 results about "Liquidambar formosana" patented technology

The invention relates to a traditional Chinese medicine composition with functions of tonifying qi and nourishing blood for livestock. The traditional Chinese medicine composition comprises the following components in parts by weight: 10-30 parts of astragalus membranaceus, 10-40 parts of spina gleditsiae, 10-20 parts of angelica sinensis, 10-20 parts of codonopsis pilosula, 10-30 parts of uniflower swisscentaury root, 10-30 parts of ligusticum wallichii, 10-20 parts of cowherb seed, 10-20 parts of fruit of liquidambar formosana hance and 1-10 parts of iron sucrose. The traditional Chinese medicine composition is scientific and reasonable in component, free of toxic and side effects and medicine residue, convenient to take and low in cost, has the functions of tonifying qi and nourishing blood, stimulating the menstrual flow and prompting lactation, and is capable of effectively treating diseases of postpartum hypogalactia, breast milk stoppage and the like which are normal in livestock.

1.The name of the design product: cosmetic bag (maple dye ginkgo leaf). 2.The use of the design product: for placing cosmetic supplies. 3.The design points of the design product: the combination of shape, pattern and color. 4.The picture or photo that best shows the design points: perspective view. 5.The design claimed contains color.

This invention provides a medicinal ointment for treating rhinitis based on a traditional Chinese medicine compound and its preparation method, relating to the field of traditional Chinese medicine technology. The medicinal ointment for treating rhinitis based on a traditional Chinese medicine compound comprises the following components in parts by weight: Bupleurum chinense 2-10 parts, Dictamnus dasycarpus root bark 3-7 parts, Magnolia biondii flower 8-12 parts, Xanthium sibiricum fruit 4-10 parts, Centipeda minima 2-6 parts, Liquidambar formosana fruit 6-10 parts, Chrysanthemum indicum flower 6-10 parts, Angelica dahurica root 6-12 parts, Houttuynia cordata flower 8-12 parts, Borneol 1-3 parts, Menthol 1-3 parts, Ligusticum chuanxiong rhizome 5-13 parts, Scutellaria baicalensis root 8-12 parts. The ingredients are: 5-11 parts licorice root, 9-10 parts calamus, 1-5 parts Fritillaria thunbergii, 2-6 parts Gleditsia sinensis thorns, 6-10 parts Saposhnikovia divaricata, 8-12 parts Cynanchum paniculatum, 3-9 parts Kochia scoparia, 1-2 parts artificial musk, 5-8 parts ginger, 3-4 parts myrrh, 4-6 parts Schisandra chinensis, 1-3 parts petrolatum, 1-3 parts beeswax, and 2-3 parts coconut oil. In this invention, myrrh reduces acute inflammatory reactions of the nasal mucosa through its anti-inflammatory effect, while Schisandra chinensis reduces secretions through its astringent effect. The combination of the two can effectively relieve nasal congestion and runny nose symptoms.

This invention provides a topical medicine composition for clearing heat, reducing swelling, and resolving blood stasis in the acute phase, along with its application and preparation method, belonging to the field of traditional Chinese medicine formulation technology. This topical medicine composition for clearing heat, reducing swelling, and resolving blood stasis in the acute phase consists of the following raw material components in parts by weight: 5-8 parts raw Phellodendron bark, 2-5 parts borneol, 8-12 parts red peony root, 4-8 parts Panax notoginseng tablets, 4-6 parts stir-fried ground beetle, 2-4 parts prepared myrrh, 2-4 parts prepared frankincense, 5-8 parts prepared Arisaema, 8-12 parts Liquidambar formosana, 8-12 parts Angelica dahurica, 8-12 parts peppermint, and 8-12 parts Trichosanthes kirilowii. This topical medicine composition for clearing heat, reducing swelling, and resolving blood stasis in the acute phase selects traditional Chinese medicinal materials with relatively weak blood-activating effects, which can avoid the risk of increased bleeding and swelling during acute use, achieving safe and effective early intervention for ankle or other injuries in the acute phase, thereby shortening the patient's recovery time.

This invention discloses a traditional Chinese medicine composition for reducing swelling and relieving pain, and its preparation method. The composition comprises the following medicinal ingredients: *Lycopodium clavatum*, *Clematis chinensis*, safflower, ephedra, *Pinus tabuliformis*, *Liquidambar formosana*, *Millettia speciosa*, *Tinospora sinensis*, *Caesalpinia sappan*, *Sparganium stoloniferum* (processed with vinegar), *Curcuma zedoaria*, and *Homalomena occulta*. All ingredients in this composition are natural Chinese herbal medicines, making the raw materials readily available, the preparation method simple, the cost low, and the use convenient. It can be mass-produced. This composition can effectively relieve symptoms of swelling and pain, improve the quality of life, and has high social value.

This invention belongs to the field of traditional Chinese medicine, specifically relating to a traditional Chinese medicine composition for treating hyperuricemia complicated with metabolic syndrome, its preparation method, and its application. The traditional Chinese medicine composition comprises the following components in parts by weight: Codonopsis pilosula 3-6 parts, Astragalus membranaceus 12-18 parts, Bupleurum chinense 1-5 parts, Citrus reticulata peel 1-5 parts, Citrus aurantium peel 3-6 parts, Scutellaria baicalensis 1-5 parts, Nelumbo nucifera leaf 3-6 parts, Crataegus pinnatifida 3-6 parts, Anemarrhena asphodeloides 12-18 parts, Coptis chinensis 1-3 parts, Polygonatum sibiricum 3-6 parts, Pueraria lobata 28-35 parts, Schisandra chinensis 1-5 parts, Smilax glabra 28-35 parts, Cimicifuga foetida 1-5 parts, processed chicken gizzard lining 5-10 parts, Lycopus lucidus 3-6 parts, Atractylodes lancea 3-6 parts, Phellodendron chinense 3-6 parts, and Liquidambar formosana 3-6 parts. The traditional Chinese medicine composition of this invention follows the theory of traditional Chinese medicine compatibility, and synergistically achieves the effects of strengthening the spleen and soothing the liver, resolving phlegm and drying dampness, clearing heat and removing blood stasis. By effectively reducing the levels of blood uric acid, triglycerides, systolic blood pressure and diastolic blood pressure, and regulating key indicators such as high-density lipoprotein, it significantly improves the clinical symptoms of patients with hyperuricemia and metabolic syndrome. Moreover, it has good safety in clinical application and no obvious adverse reactions.

This invention belongs to the field of traditional Chinese medicine. Specifically, it relates to a traditional Chinese medicine composition, preparation method, and application for treating ankylosing spondylitis. The raw materials include 10-20 parts of Achyranthes bidentata, 10-20 parts of Dipsacus asper, 5-15 parts of Astragalus complanatus, 5-15 parts of Curculigo orchioides, 10-15 parts of Spatholobus suberectus, 10-20 parts of Salvia miltiorrhiza, 5-10 parts of Liquidambar formosana, 5-10 parts of Clematis chinensis, 10-15 parts of Clematis armandii, 5-15 parts of Pinus massoniana, and 5-15 parts of Scrophularia ningpoensis. This formula is meticulously formulated, addressing both the root cause and the symptoms: it combines tonification and purgation, nourishing the liver and kidneys to treat the root cause, while also dispelling wind and cold, and promoting blood circulation to treat the symptoms. This formula can be used to treat ankylosing spondylitis with symptoms of liver and kidney deficiency, qi and blood stagnation, and cold-dampness obstruction, such as pain, stiffness, and limited mobility in the spine or sacroiliac joints, with significant stiffness upon waking and relief after activity, or accompanied by peripheral joint pain, aversion to cold, cold limbs, dark tongue or ecchymosis, and a deep, hesitant or wiry pulse.